10:18 | 25.05.2011
Research and Markets: Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry
Research and Markets (http://www.researchandmarkets.com/research/a64a21/global_water_marke)
has announced the addition of Frost & Sullivan’s new report “Global
Water Market Outlook: Strategic Analysis of Water and Wastewater
Management in the Pharmaceutical Industry” to their offering.
Pharmaceutical Boom in Asia Beckons Water and Wastewater Management
Companies
North America and Europe have traditionally been the major
pharmaceutical producers. However, in recent years, because of increased
demand from local population and low production costs, new markets such
as India, China, Brazil and Russia, among others, have emerged. The
growing pharmaceutical infrastructure in these emerging markets is
spurring the demand for high-purity water systems, creating opportunity
for water management companies. In addition, many developed and
developing nations are imposing stringent effluent standards on the
wastewater discharged from drug manufacturing facilities, in order to
prevent contamination of water streams.
The most important factor driving growth is the emergence of Asian
countries such as India and China as key manufacturing hub for generic
drugs and APIs, notes the analyst of this research. India has over 100
FDA approved drug manufacturing facilities – the highest for any country
outside USA. The Asian market for water and wastewater treatment
equipment in the pharmaceutical industry is expected to grow at a
compound annual growth rate of 16.5 per cent from 2010 to 2017.
Stricter Discharge Standards in Established Markets to Compel Focus on
Sustainable and Advanced Water Treatment Technologies
Pharmaceutical companies in North America and Europe are outsourcing
certain portions of the drug production process to Asian countries and
are keen to focus more on research and drug development. This move could
reduce the number of new pharmaceutical production facilities in these
regions in the future. In North America and Europe, the replacement and
refurbishment segment are anticipated to offer more potential than new
builds, remarks the analyst. With many countries in these regions
outsourcing their operations to Asian countries the water and wastewater
treatment equipment market in these regions is expected to grow at the
rate of around 5-6% annually.
In North America and Europe, effluent discharge standards for
pharmaceutical production facilities are set to become more stringent in
the future. Strict effluent discharge standards will force
pharmaceutical production facilities to adopt advanced treatment
technologies and also focus on sustainable technologies that would
facilitate the generation of energy from their wastewater, concludes the
analyst. This would enable them to reduce the operational costs
associated with wastewater treatment plants.
Technology
The following technologies are covered in the research:
Reverse Osomosis/DMI
EDI, UF/MF
Ion exchange
Disinfection UV/ozone
This Frost & Sullivan research service titled Global
Water Market Outlook: Strategic Analysis of Water and Wastewater
Management in the Pharmaceutical Industry analyses the market from
various perspectives such as global, technology, economic, customers,
industry, competition and best practices. In this research, Frost &
Sullivan’s expert analysts thoroughly examine the opportunity for water
management in the global pharmaceutical industry.
Companies Mentioned:
Neela India
Hager + Elsasser
Ion Exchange India Ltd
Veolia Water Solutions and Technologies
Pharmatec
For more information visit http://www.researchandmarkets.com/research/a64a21/global_water_marke
|
